The aim of this project was to examine the Streptococcal IgA1 proteases, with particular interest on the Streptococcus pneumoniae enzyme. IgA1 protease of S. pneumoniae was identified and characterised. A non-reducing polyacrylamide gel system was employed to screen clinical isolates for IgA1 protease activity. Of 187 isolates tested 18% were found to be IgA1 protease negative, there was no correlation with the site of isolation of the organism and its ability to produce the enzyme. Attempts were made to clone the pneumococcal IgA1 protease gene using the cosmid pEMBLcos4, the plasmid vector pLG339 and the ? replacement vector ?EMB4. Libraries were screened for pneumolysin and IgA1 protease activity. Clones that expressed pneumolysin were identified by overlaying with sheep red blood cells. One haemolytic clone was not inhibited in the presence of cholesterol. Screening for IgA1 protease activity identified clones with IgA1 protease-ike activity but this activity was not stably expressed. Closer analysis of the libraries suggested that pneumococcal DNA was highly unstable when cloned into E. coil plasmid and cosmid vectors.

Hemophilus influenzae (Hi) has been an important strain in clinical examination, but it is not clear about its subtype, non-typable Hi, in causing invasive diseases after years of application of vaccines against typable Hi. Thus, the study is to determine the major infected bacterium causing invasive diseases and investigate the genotype relationship between antibiotic resistance and active IgA1 protease. Practical approaches of the study include clone each microorganism from infected blood, pus, sputum, bronchial washing and thorax samples of patients with invasive diseases. Each of the organisms was assayed for IgA1 protease activity, the type of the enzyme and antibiotic resistance. Forty-five patients aged 1 to over 71 with invasive diseases of diagnosed pneumonia, sinusitis, bacteremia, bronchitis, chronic obstructive of pulmonary diseases (COPD), conjunctivitis or otitis media, were analyzed, and all the 45 Hi isolates contain iga gene but only 80% contain active IgA1 protease. Mutations to silence iga gene are common in Hi isolates. The dominant population of infected bacterium is Hi, 84% of which are non-typable (NTHi). About 76% of NTHi and 85% of typable Hi (THi) contained active IgA1 protease. PFGE analysis showed that none of the 45 Hi isolates had identical genome. Phenotypes of active IgA1 protease and antibiotic resistance of the 45 Hi isolates showed no close relations each other. This study clearly demonstrated that NTHi has become a dominant strain in causing invasive diseases. Antibiotic resistance and active IgA1 protease are two essential but independent phenotypes for NTHi to infect and colonize. Antibiotic resistance of NTHi is dependent on the presence of beta-lactamase.

IgA1 (immunoglobulin A1), a predominant immunoglobulin, is at the first defense line against microbial pathogens infection and invasion, to neutralize pathogenic antigens. Some bacterial pathogens, such as Neisseria meningitidis and Haemophilus influenzae, however, secrete site-specific IgA1 proteases to counteract with the human defense system. The protease is capable of cleaving at the hinge region of immunoglobulin A1 to destroy the structure and function of human IgA1, impairing the role of the immunoglobulin from the host defense. The protease has therefore been implicated as a putative virulence factor that contributes to bacterial colonization, but bacterial isolates from patients with invasive diseases contain both positive and negative IgA1 proteases. To clarify the role of IgA1 protease in bacterial infection, this project is designed to reveal the molecular mechanism of the protease in bacterial infection and colonization. To do this, iga genes encoding non-typable H. influenzae type 1, type 3 and Neisseria meningitidis type 3 IgA1 proteases were isolated, sequenced and then expressed in IgA1 protease-negative E. coli BL21 (DE3). The recombinant proteases have been purified to homogeneity using ion exchange chromatography. Comparison of the deduced amino acid sequences from non-typable H. influenzae IgA1 proteases with other published H. influenzae IgA1 protease revealed a high degree of homology. Sequence analysis indicates that both type 1 and type 3 non-typable H. influenzae IgA1 proteases lack £\-protein in comparison with the iga from N. meningitidis. The role of IgA1 protease in relation to deposition and invasion has also been evaluated in human lung carcinoma cell (A549) model. The results suggest that the IgA1 protease plays a role in the adherence of H. influenzae on epithelial cell surface though the best effectiveness varies upon different pathogenic bacterial strains at different concentrations.

Immunoglobulin A¡]IgA¡^, the principal antibody class in secretions that bathe mucosal surfaces, acts as an important first line of defense. However, some pathogenic bacteria such as Haemophilus influenzae can produce IgA1 proteases to impair IgA1, especially in human mucosal immune system. IgA1 proteases are characterized by a polypeptide precursor containing four domains, the signal peptide, protease, linking region and the £]-domain. The function of the protease and the £]-domain (£] core) had been studied extensively, but the linking region is less defined, let alone its function. To complete the project, the DNA fragment for linking region was amplified by PCR from iga gene (Gene Bank DQ683353) spanning from NT3130 to NT4686, and then transferred to pGEX-2T for expression. Recombinant linking region-protein was purified using glutathione-Sepharose column. The proliferation assay showed that purified recombinant protein did not enhance cell growth significantly at the concentration of 1 £gg/ml compared to either the negative control or GST control; but when the concentration of the recombinant protein was increased to 5 £gg/ml or 10 £gg/ml, the cell proliferation was significantly stimulated. These results suggest that recombinant linking region-protein contains special element that stimulates the jurkat cell.

Some pathogenic bacteria including Haemophilus influenzae and Neisseria meningitides produce a protease called IgA1 protease to impair a major antibody, immunoglobulin A1 (IgA1), on human mucosal surfaces. The iga mRNA is initially translated into a precursor containing four distinct domains: a 31-amino acids signal peptide which leads the precursor to the periplasmic space, an 105-kDa protease domain which cleaves host IgA1 molecule, a £]-domain responsible for autotransportation of the protease domain, and a short linker between the protease and the £]-domains. The autotransporter £]-domain can be further divided into three subdomains in Neisseria protease: an extracellular linking region £\-protein and a membrane-embedded £]-core, between which there is a distinguished sequence called surface region. The hydrolytic function of the protease and the transporter role of £]-core had been studied extensively, but the £\-protein and the surface regions were less defined, or had their role characterized. Thus this study is designed to reveal the possible pathogenic functions of the £\-protein and the surface region in bacterial adherence to human cell surfaces. To complete this project, recombinant £\-protein and the surface region were expressed in IgA1 protease-negative E. coli strain (UT5600) respectively and purified to homogeneity. These recombinant proteins were used in cellular assays for bacterial adhesion on human lung cancer cell (A549). Four different invasive strains of pathogenic bacteria (IgA1 protease-positive or negative), were recruited in adherence assays to determine the effect of the purified £\-protein and the surface region on bacterial adherence to A549 cells. Results showed that the both £\-protein and the surface region played a role in bacterial adherence in a species-dependent manner.

No description available.